Biogen/$BIIB
About Biogen
Ticker
Industry
Employees
Biogen Metrics
$22B
13.58
$11.06
-0.06
-
Price and volume
Market cap
$22B
Beta
-0.06
52-week high
$252.17
52-week low
$145.07
Average daily volume
1.4M
Financial strength
Current ratio
1.259
Quick ratio
0.68
Long term debt to equity
29.97
Total debt to equity
40.656
Interest coverage (TTM)
5.16%
Management effectiveness
Return on assets (TTM)
4.99%
Return on equity (TTM)
10.47%
Valuation
Price to earnings (TTM)
13.577
Price to revenue (TTM)
2.271
Price to book
1.34
Price to tangible book (TTM)
323.69
Price to free cash flow (TTM)
12.339
Growth
Revenue change (TTM)
-3.86%
Earnings per share change (TTM)
10.05%
3-year revenue growth (CAGR)
-4.70%
3-year earnings per share growth (CAGR)
2.68%
What the Analysts think about Biogen
Analyst Ratings
Biogen Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
Biogen Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
Biogen News
Biogen CEO sees no burning need for more acquisitions
FDA Accepts LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease
Sage Therapeutics shares surge on unsolicited takeover bid from Biogen
FAQs
What’s the current market cap for Biogen stock?
What is the P/E ratio for Biogen stock?
Does Biogen stock pay dividends?
No, Biogen (BIIB) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Biogen dividend payment date?
Biogen (BIIB) stock does not pay dividends to its shareholders.
What is the beta indicator for Biogen?
Biogen (BIIB) has a beta rating of -0.06. This means that it has an inverse relation to market volatility.